92 related articles for article (PubMed ID: 8343170)
1. Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide.
Anderson DC; Nichols E; Manger R; Woodle D; Barry M; Fritzberg AR
Biochem Biophys Res Commun; 1993 Jul; 194(2):876-84. PubMed ID: 8343170
[TBL] [Abstract][Full Text] [Related]
2. Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography.
Serrière J; Dugua JM; Bossus M; Verrier B; Haser R; Gouet P; Guillon C
J Mol Biol; 2011 Jan; 405(1):33-42. PubMed ID: 21035463
[TBL] [Abstract][Full Text] [Related]
3. Identification of a nuclear transport inhibitory signal (NTIS) in the basic domain of HIV-1 Vif protein.
Friedler A; Zakai N; Karni O; Friedler D; Gilon C; Loyter A
J Mol Biol; 1999 Jun; 289(3):431-7. PubMed ID: 10356319
[TBL] [Abstract][Full Text] [Related]
4. HIV TAT basic peptide is not a high-affinity ligand for VEGF receptor 2.
Rubio Demirovic A; Canadi J; Weiglhofer W; Scheidegger P; Jaussi R; Kurt BH
Biol Chem; 2003; 384(10-11):1435-41. PubMed ID: 14669986
[TBL] [Abstract][Full Text] [Related]
5. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
Ziegler A; Nervi P; Dürrenberger M; Seelig J
Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
[TBL] [Abstract][Full Text] [Related]
6. Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.
Mancini N; Perotti M; Carletti S; Canducci F; Sampaolo M; Clementi M; Burioni R
Mol Immunol; 2006 Mar; 43(9):1363-9. PubMed ID: 16199090
[TBL] [Abstract][Full Text] [Related]
7. Acid wash in determining cellular uptake of Fab/cell-permeating peptide conjugates.
Kameyama S; Horie M; Kikuchi T; Omura T; Tadokoro A; Takeuchi T; Nakase I; Sugiura Y; Futaki S
Biopolymers; 2007; 88(2):98-107. PubMed ID: 17252560
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cellular uptake with a cobaltacarborane-porphyrin-HIV-1 Tat 48-60 conjugate.
Sibrian-Vazquez M; Hao E; Jensen TJ; Vicente MG
Bioconjug Chem; 2006; 17(4):928-34. PubMed ID: 16848399
[TBL] [Abstract][Full Text] [Related]
10. Effects of cell-permeating peptide binding on the distribution of 125I-labeled Fab fragment in rats.
Kameyama S; Horie M; Kikuchi T; Omura T; Takeuchi T; Nakase I; Sugiura Y; Futaki S
Bioconjug Chem; 2006; 17(3):597-602. PubMed ID: 16704196
[TBL] [Abstract][Full Text] [Related]
11. Site-specific cross-linking of amino acids in the basic region of human immunodeficiency virus type 1 Tat peptide to chemically modified TAR RNA duplexes.
Farrow MA; Aboul-ela F; Owen D; Karpeisky A; Beigelman L; Gait MJ
Biochemistry; 1998 Mar; 37(9):3096-108. PubMed ID: 9485463
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
13. Recognition of defined epitopes by affinity-purified anti-immunoglobulin fab autoantibodies isolated from HIV-infected humans.
Marchalonis JJ; Garza A; Lake DF; Landsperger WJ; Süsal C
J Mol Recognit; 1999; 12(3):169-76. PubMed ID: 10398407
[TBL] [Abstract][Full Text] [Related]
14. Interactions of the HIV-1 Tat and RAP74 proteins with the RNA polymerase II CTD phosphatase FCP1.
Abbott KL; Archambault J; Xiao H; Nguyen BD; Roeder RG; Greenblatt J; Omichinski JG; Legault P
Biochemistry; 2005 Mar; 44(8):2716-31. PubMed ID: 15723517
[TBL] [Abstract][Full Text] [Related]
15. Intracellular cargo delivery using tat peptide and derivatives.
Zhao M; Weissleder R
Med Res Rev; 2004 Jan; 24(1):1-12. PubMed ID: 14595670
[TBL] [Abstract][Full Text] [Related]
16. Chemical cross-linking of the human immunodeficiency virus type 1 Tat protein to synthetic models of the RNA recognition sequence TAR containing site-specific trisubstituted pyrophosphate analogues.
Naryshkin NA; Farrow MA; Ivanovskaya MG; Oretskaya TS; Shabarova ZA; Gait MJ
Biochemistry; 1997 Mar; 36(12):3496-505. PubMed ID: 9131999
[TBL] [Abstract][Full Text] [Related]
17. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
Cao H; Tamilarasu N; Rana TM
Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
[TBL] [Abstract][Full Text] [Related]
18. Humoral immune response to fibrillar beta-amyloid peptide.
Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
[TBL] [Abstract][Full Text] [Related]
19. Biological evaluation of penetration domain and killing domain peptides.
Jarajapu YP; Baltunis J; Knot HJ; Sullivan SM
J Gene Med; 2005 Jul; 7(7):908-17. PubMed ID: 15832372
[TBL] [Abstract][Full Text] [Related]
20. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
